Micardis 80mg 14 Tabs, Telmisartan
THIS IS A BRAND MEDICATION
THERAPEUTIC INDICATIONS: * MICARDIS (telmisartan) is indicated for the treatment of essential hypertension.
CONTRAINDICATIONS: Hypersensitivity to any of the ingredients. During pregnancy and lactation. In patients with obstructive disease of the bile ducts and severe hepatic failure.
Renovascular hypertension: Risk of severe hypotension and renal insufficiency when patients with bilateral stenosis of renal artery stenosis or artery of a functioning kidney are treated with drugs affecting the renin-angiotensin-aldosterone system.
Renal failure and kidney transplantation: MICARDIS * When given to patients with renal insufficiency is recommended continued monitoring of plasma potassium and creatinine. There is no experience with the drug's use in patients with recent kidney transplant.
Intravascular volume depletion, can occur manifestations symptomatic hypotension, especially after the first dose administration in patients with volume depletion and / or sodium after extensive treatment with diuretics in salt-restricted diets, diarrhea or vomiting. These conditions, especially volume depletion and / or sodium should be corrected prior to administration of MICARDIS *.
Other conditions with stimulation of the renin-angiotensin-aldosterone system: In patients whose vascular tone and renal function depend predominantly on the activity of the renin-angiotensin-aldosterone system (eg patients with severe congestive heart failure or underlying renal disease, including renal artery stenosis), treatment with drugs that affect this system has been associated with acute hypotension, azotemia, oliguria, and rarely with acute renal failure.
DOSAGE AND ADMINISTRATION: Oral.
The recommended dose is 40 to 80 mg once a day. Some patients may benefit from a dose of 20 mg. In cases where failure to obtain the expected decline in blood pressure, may be increased to 80 mg a day.
When considering an increase in dosage should be noted that the maximum antihypertensive effect is usually obtained after 4 to 8 weeks after starting treatment.
In patients with severe hypertension have used dosages higher than 160 mg alone or in combination with 12.5 to 25 mg of hydrochlorothiazide daily, they have been effective and welltolerated.
No dose adjustment is necessary in patients with renal impairment, including hemodialysis.The drug is not withdrawn from circulation by hemofiltration. In patients with hepatic impairment or moderate, the maximum recommended daily dose is 40 mg. In elderly subjectsis not necessary dosage adjustments.
No information on the safety and efficacy of MICARDIS * in children and adolescents.
MICARDIS * can be administered before or after food.
Medication name: Micardis
Comparable patent medicine: Micardis
Active ingredient: Telmisartan
Extended-release tablets: No
Lab: Boehringer Ingelheim promise, Inc. de CV
Box with 28 pills
Made in: Mexico